Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148


Nrf2 pathway regulates multidrug-resistance-associated protein 1 in small cell lung cancer.

Ji L, Li H, Gao P, Shang G, Zhang DD, Zhang N, Jiang T.

PLoS One. 2013 May 7;8(5):e63404. doi: 10.1371/journal.pone.0063404. Print 2013.


Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway.

Xu X, Zhang Y, Li W, Miao H, Zhang H, Zhou Y, Li Z, You Q, Zhao L, Guo Q.

Biochem Pharmacol. 2014 Nov 15;92(2):220-34. doi: 10.1016/j.bcp.2014.09.008. Epub 2014 Sep 28.


6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer.

Filomeni G, Turella P, Dupuis ML, Forini O, Ciriolo MR, Cianfriglia M, Pezzola S, Federici G, Caccuri AM.

Mol Cancer Ther. 2008 Feb;7(2):371-9. doi: 10.1158/1535-7163.MCT-07-0487.


15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells.

Song NY, Kim DH, Kim EH, Na HK, Surh YJ.

Ann N Y Acad Sci. 2009 Aug;1171:210-6. doi: 10.1111/j.1749-6632.2009.04914.x.


Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.

Singh A, Wu H, Zhang P, Happel C, Ma J, Biswal S.

Mol Cancer Ther. 2010 Aug;9(8):2365-76. doi: 10.1158/1535-7163.MCT-10-0108. Epub 2010 Aug 3.


Fasting induces nuclear factor E2-related factor 2 and ATP-binding Cassette transporters via protein kinase A and Sirtuin-1 in mouse and human.

Kulkarni SR, Donepudi AC, Xu J, Wei W, Cheng QC, Driscoll MV, Johnson DA, Johnson JA, Li X, Slitt AL.

Antioxid Redox Signal. 2014 Jan 1;20(1):15-30. doi: 10.1089/ars.2012.5082. Epub 2013 Jul 31.


Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.

Chen CC, Chu CB, Liu KJ, Huang CY, Chang JY, Pan WY, Chen HH, Cheng YH, Lee KD, Chen MF, Kuo CC, Chen LT.

Biochem Pharmacol. 2013 Oct 1;86(7):872-87. doi: 10.1016/j.bcp.2013.07.025. Epub 2013 Aug 8.


Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.

Guo L, Liu Y, Bai Y, Sun Y, Xiao F, Guo Y.

Eur J Cancer. 2010 Jun;46(9):1692-702. doi: 10.1016/j.ejca.2010.02.043. Epub 2010 Apr 3.


[Role of SPHK1 regulates multi-drug resistance of small cell lung cancer 
and its clinical significance].

Yang L, Hu H, Deng Y, Bai Y.

Zhongguo Fei Ai Za Zhi. 2014 Nov;17(11):769-77. doi: 10.3779/j.issn.1009-3419.2014.11.01. Chinese.


Cryptotanshinone Reverses Cisplatin Resistance of Human Lung Carcinoma A549 Cells through Down-Regulating Nrf2 Pathway.

Xia C, Bai X, Hou X, Gou X, Wang Y, Zeng H, Huang M, Jin J.

Cell Physiol Biochem. 2015;37(2):816-24. doi: 10.1159/000430398. Epub 2015 Sep 11.


Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.

Vollrath V, Wielandt AM, Iruretagoyena M, Chianale J.

Biochem J. 2006 May 1;395(3):599-609.


miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1.

Liu H, Wu X, Huang J, Peng J, Guo L.

Int J Exp Pathol. 2015 Aug;96(4):240-7. doi: 10.1111/iep.12131. Epub 2015 Jun 24.


Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival.

Ji L, Wei Y, Jiang T, Wang S.

Int J Clin Exp Pathol. 2014 Feb 15;7(3):1124-31. eCollection 2014.


Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.

Xiao Z, Ding N, Xiao G, Wang S, Wu Y, Tang L.

Anat Rec (Hoboken). 2012 Dec;295(12):2122-8. doi: 10.1002/ar.22552. Epub 2012 Aug 21.


Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.

Song NY, Kim DH, Kim EH, Na HK, Kim NJ, Suh YG, Surh YJ.

Chem Res Toxicol. 2011 Aug 15;24(8):1231-41. doi: 10.1021/tx200090n. Epub 2011 Jul 25.


RNAi-based knockdown of multidrug resistance-associated protein 1 is sufficient to reverse multidrug resistance of human lung cells.

Shao SL, Cui TT, Zhao W, Zhang WW, Xie ZL, Wang CH, Jia HS, Liu Q.

Asian Pac J Cancer Prev. 2014;15(24):10597-601.


Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.

Zhan L, Zhang H, Zhang Q, Woods CG, Chen Y, Xue P, Dong J, Tokar EJ, Xu Y, Hou Y, Fu J, Yarborough K, Wang A, Qu W, Waalkes MP, Andersen ME, Pi J.

Free Radic Biol Med. 2012 Aug 15;53(4):758-68. doi: 10.1016/j.freeradbiomed.2012.05.041. Epub 2012 Jun 7.

Supplemental Content

Support Center